ClinicalTrials.gov
public full text
Public Domain
Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment
This study evaluates the effects of Ginkgo biloba on blood biomarkers related to Alzheimer's disease in patients with mild cognitive impairment. Participants will be randomly assigned to receive either Ginkgo biloba or a placebo for 6 months. Changes in blood biomarkers, including p-tau217 and neurofilament light (NfL), as well as cognitive function, will be assessed to determine whether Ginkgo biloba may influence disease-related biological processes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment for Early Memory Loss#1340170
- Effect of Ginkgo Biloba Extract on Cognitive Function in Acute Ischemic Stroke#1139330
- Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis#1007709
- Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults#810319
- Ginkgo biloba as an alternative medicine in the treatment of anxiety in dementia and other psychiatric disorders#936041
Record · ID 1279943
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive